These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
824 related articles for article (PubMed ID: 30553058)
1. Enhancement of the apparent solubility and bioavailability of Tadalafil nanoparticles via antisolvent precipitation. Rao Q; Qiu Z; Huang D; Lu T; Zhang ZJ; Luo D; Pan P; Zhang L; Liu Y; Guan S; Li Q Eur J Pharm Sci; 2019 Feb; 128():222-231. PubMed ID: 30553058 [TBL] [Abstract][Full Text] [Related]
2. Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique. Zu Y; Wu W; Zhao X; Li Y; Wang W; Zhong C; Zhang Y; Zhao X Int J Pharm; 2014 Aug; 471(1-2):366-76. PubMed ID: 24882039 [TBL] [Abstract][Full Text] [Related]
3. Physicochemical properties of tadalafil solid dispersions - Impact of polymer on the apparent solubility and dissolution rate of tadalafil. Wlodarski K; Sawicki W; Haber K; Knapik J; Wojnarowska Z; Paluch M; Lepek P; Hawelek L; Tajber L Eur J Pharm Biopharm; 2015 Aug; 94():106-15. PubMed ID: 25998701 [TBL] [Abstract][Full Text] [Related]
4. Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles. Liu Y; Sun C; Hao Y; Jiang T; Zheng L; Wang S J Pharm Pharm Sci; 2010; 13(4):589-606. PubMed ID: 21486533 [TBL] [Abstract][Full Text] [Related]
5. Development of megestrol acetate solid dispersion nanoparticles for enhanced oral delivery by using a supercritical antisolvent process. Ha ES; Kim JS; Baek IH; Yoo JW; Jung Y; Moon HR; Kim MS Drug Des Devel Ther; 2015; 9():4269-77. PubMed ID: 26345723 [TBL] [Abstract][Full Text] [Related]
6. Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP. Homayouni A; Sadeghi F; Varshosaz J; Garekani HA; Nokhodchi A Eur J Pharm Biopharm; 2014 Sep; 88(1):261-74. PubMed ID: 24952357 [TBL] [Abstract][Full Text] [Related]
7. Antisolvent precipitation technique: A very promising approach to crystallize curcumin in presence of polyvinyl pyrrolidon for solubility and dissolution enhancement. Sadeghi F; Ashofteh M; Homayouni A; Abbaspour M; Nokhodchi A; Garekani HA Colloids Surf B Biointerfaces; 2016 Nov; 147():258-264. PubMed ID: 27518458 [TBL] [Abstract][Full Text] [Related]
8. Physicochemical properties of direct compression tablets with spray dried and ball milled solid dispersions of tadalafil in PVP-VA. Wlodarski K; Tajber L; Sawicki W Eur J Pharm Biopharm; 2016 Dec; 109():14-23. PubMed ID: 27658987 [TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of betulin nanoparticles for oral hypoglycemic drug by antisolvent precipitation. Zhao X; Wang W; Zu Y; Zhang Y; Li Y; Sun W; Shan C; Ge Y Drug Deliv; 2014 Sep; 21(6):467-79. PubMed ID: 24479653 [TBL] [Abstract][Full Text] [Related]
10. The influence of amorphization methods on the apparent solubility and dissolution rate of tadalafil. Wlodarski K; Sawicki W; Paluch KJ; Tajber L; Grembecka M; Hawelek L; Wojnarowska Z; Grzybowska K; Talik E; Paluch M Eur J Pharm Sci; 2014 Oct; 62():132-40. PubMed ID: 24907679 [TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of micronized ellagic acid using antisolvent precipitation for oral delivery. Li Y; Zhao X; Zu Y; Zhang Y; Ge Y; Zhong C; Wu W Int J Pharm; 2015; 486(1-2):207-16. PubMed ID: 25841566 [TBL] [Abstract][Full Text] [Related]
12. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats. Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980 [TBL] [Abstract][Full Text] [Related]
13. Use of acidifier and solubilizer in tadalafil solid dispersion to enhance the in vitro dissolution and oral bioavailability in rats. Choi JS; Kwon SH; Lee SE; Jang WS; Byeon JC; Jeong HM; Park JS Int J Pharm; 2017 Jun; 526(1-2):77-87. PubMed ID: 28450170 [TBL] [Abstract][Full Text] [Related]
14. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability. Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445 [TBL] [Abstract][Full Text] [Related]
15. Promising dissolution enhancement effect of soluplus on crystallized celecoxib obtained through antisolvent precipitation and high pressure homogenization techniques. Homayouni A; Sadeghi F; Varshosaz J; Afrasiabi Garekani H; Nokhodchi A Colloids Surf B Biointerfaces; 2014 Oct; 122():591-600. PubMed ID: 25124835 [TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of amorphous amphotericin B nanoparticles for oral administration through liquid antisolvent precipitation. Zu Y; Sun W; Zhao X; Wang W; Li Y; Ge Y; Liu Y; Wang K Eur J Pharm Sci; 2014 Mar; 53():109-17. PubMed ID: 24345795 [TBL] [Abstract][Full Text] [Related]
17. Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process. Kim MS; Jin SJ; Kim JS; Park HJ; Song HS; Neubert RH; Hwang SJ Eur J Pharm Biopharm; 2008 Jun; 69(2):454-65. PubMed ID: 18359211 [TBL] [Abstract][Full Text] [Related]
18. Development of an amorphous nanosuspension by sonoprecipitation-formulation and process optimization using design of experiment methodology. Gajera BY; Shah DA; Dave RH Int J Pharm; 2019 Mar; 559():348-359. PubMed ID: 30721724 [TBL] [Abstract][Full Text] [Related]
19. In vitro dissolution enhancement of micronized l-nimodipine by antisolvent re-crystallization from its crystal form H. Zu Y; Li N; Zhao X; Li Y; Ge Y; Wang W; Wang K; Liu Y Int J Pharm; 2014 Apr; 464(1-2):1-9. PubMed ID: 24456674 [TBL] [Abstract][Full Text] [Related]
20. Characterization and pharmacokinetic study of itraconazole solid dispersions prepared by solvent-controlled precipitation and spray-dry methods. Sim T; Lim C; Lee JW; Kim DW; Kim Y; Kim M; Choi S; Choi HG; Lee ES; Kim KS; Kang W; Oh KT J Pharm Pharmacol; 2017 Dec; 69(12):1707-1715. PubMed ID: 28872678 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]